Immunomodulatory Drugs for the Treatment of B Cell Malignancies

Accumulating evidence suggests that the tumor microenvironment (TME) is involved in disease progression and drug resistance in B cell malignancies, by supporting tumor growth and facilitating the ability of malignant cells to avoid immune recognition. Immunomodulatory drugs (IMiDs) such as lenalidom...

Descripción completa

Detalles Bibliográficos
Autores principales: Ioannou, Nikolaos, Jain, Khushi, Ramsay, Alan G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395307/
https://www.ncbi.nlm.nih.gov/pubmed/34445275
http://dx.doi.org/10.3390/ijms22168572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395307/
https://www.ncbi.nlm.nih.gov/pubmed/34445275
http://dx.doi.org/10.3390/ijms22168572

Ejemplares similares